BackLuye Pharma Group Overview

Luye Pharma Group Other Liabilities

Latest other liabilities for LYPHF: $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Luye Pharma Group Other Liabilities History

Loading

Luye Pharma Group vs. peers: Other Liabilities Comparison

Loading

Luye Pharma Group Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Luye Pharma Group (LYPHF) FAQ

Luye Pharma Group posts a other liabilities of $0 as of June 2026. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Luye Pharma Group's other liabilities was $0. The latest reading is $0 (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Other Liabilities is one piece of Luye Pharma Group's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for LYPHF's other liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Luye Pharma Group's other metric pages and overview cover the third.